Know
The FDA wants to pull its approval of a drug. It’s not so easy.
The regulator says Tavneos was approved on the basis of manipulated study data. Should patients still have access to it?
More in Science & Emerging Technology
- Seabirds racing home over the ocean can get jet-lagged Ars Technica
- APOD: 2026 October 31 – Night on a Spooky Planet NASA
- NASA Releases MAX POWER Key Events for Media, Participants NASA
- Once again, NASA is asking for ideas to rescue Hubble from certain death Ars Technica
- NASA’s James Webb Space Telescope Captures Eerie Cat’s Head NASA